Ticker name:CTORCITIUS ONCOLOGY, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

Market Cap 53M

Last close 0.57$

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.1T1146.9$
2JNJJOHNSON & JOHNSON599B248.82$
3ABBVAbbVie Inc.448B253.38$
4MRKMerck & Co., Inc.307B124.4$
5NVSNOVARTIS AG285B149.56$
6AZNASTRAZENECA PLC255B164.52$
7AMGNAMGEN INC197B364.17$
8GILDGILEAD SCIENCES, INC.165B133.21$
9PFEPFIZER INC141B24.75$
10BMYBRISTOL MYERS SQUIBB CO123B60.16$
11SNYSanofi107B43.98$
12ZTSZoetis Inc.32B76.2$
13BIIBBIOGEN INC.30B199.95$
14OGNOrganon & Co.3.5B13.49$
15SCLXScilex Holding Co65M7.64$
16CTORCITIUS ONCOLOGY, INC.53M0.57$
17SRXHSRX Global Inc.42M2.17$
18MIRAMIRA PHARMACEUTICALS, INC.39M0.92$